Suppr超能文献

阿尔茨海默病患者专科护理中心的成本效益

Cost effects of a specialized care center for people with Alzheimer's disease.

作者信息

Bloom Bernard S, Chhatre Sumedha, Jayadevappa Ravi

机构信息

University of Pennsylvania, Department of Medicine, Division of Geriatrics, Pennsylvania, USA.

出版信息

Am J Alzheimers Dis Other Demen. 2004 Jul-Aug;19(4):226-32. doi: 10.1177/153331750401900406.

Abstract

A retrospective cohort control study of three populations, 65 years of age or older, at the same institution estimated the incremental cost of Alzheimer's disease (AD). The AD population of the ambulatory Alzheimer's Disease Center (ADC) (n = 640) was matched by age, gender, ethnicity, and address to one with AD from the general internal medicine practice (AD-GM) (n = 419) and to a control group without AD (n = 5331)from the same general medicine practice. Medicare costs of all care for all diagnoses were obtained for 1998 and 1999. Mean per person annual Medicare costs were $19,418 for ADC, $18, 753 for AD-GM, and $12,085 for the control group. Incremental cost for ADC population was $7,333 and $6,668 for AD-GM population compared with the control group. Incremental cost was $665 (9.1 percent) higher for ADC than AD-GM. Higher non-AD hospitalizations and length of stay (LOS) by AD populations were the main cost drivers.

摘要

在同一机构对三个65岁及以上人群进行的一项回顾性队列对照研究估计了阿尔茨海默病(AD)的增量成本。流动阿尔茨海默病中心(ADC)的AD人群(n = 640)按年龄、性别、种族和地址与普通内科诊所的AD人群(AD-GM)(n = 419)以及同一普通内科诊所的无AD对照组(n = 5331)进行匹配。获取了1998年和1999年所有诊断的所有护理的医疗保险费用。ADC人群的人均年度医疗保险费用为19418美元,AD-GM人群为18753美元,对照组为12085美元。与对照组相比,ADC人群的增量成本为7333美元,AD-GM人群为6668美元。ADC的增量成本比AD-GM高665美元(9.1%)。AD人群较高的非AD住院率和住院时间(LOS)是主要的成本驱动因素。

相似文献

1
Cost effects of a specialized care center for people with Alzheimer's disease.
Am J Alzheimers Dis Other Demen. 2004 Jul-Aug;19(4):226-32. doi: 10.1177/153331750401900406.
2
Medical management, costs, and consequences of Alzheimer's disease in Germany: an analysis of health claims data.
J Med Econ. 2015 Jun;18(6):466-73. doi: 10.3111/13696998.2015.1014090. Epub 2015 Apr 22.
3
2021 Alzheimer's disease facts and figures.
Alzheimers Dement. 2021 Mar;17(3):327-406. doi: 10.1002/alz.12328. Epub 2021 Mar 23.
4
The clinical and economic burden of newly diagnosed Alzheimer's disease in a medicare advantage population.
Am J Alzheimers Dis Other Demen. 2013 Jun;28(4):384-92. doi: 10.1177/1533317513488911. Epub 2013 May 17.
5
Gender Differences: A Lifetime Analysis of the Economic Burden of Alzheimer's Disease.
Womens Health Issues. 2015 Sep-Oct;25(5):436-40. doi: 10.1016/j.whi.2015.06.001.
6
Health service utilization among Alzheimer's disease patients: evidence from managed care.
Alzheimers Dement. 2008 Sep;4(5):361-7. doi: 10.1016/j.jalz.2008.02.007. Epub 2008 Apr 21.
9
Pre-diagnosis excess acute care costs in Alzheimer's patients among a US Medicaid population.
Appl Health Econ Health Policy. 2013 Aug;11(4):407-13. doi: 10.1007/s40258-013-0038-9.
10
Hospital incidence, mortality and costs of Alzheimer's disease in Spain: a retrospective multicenter study.
Expert Rev Pharmacoecon Outcomes Res. 2021 Oct;21(5):1101-1106. doi: 10.1080/14737167.2020.1820328. Epub 2020 Sep 14.

引用本文的文献

1
Acute Healthcare Utilization of a Multidisciplinary Neurocognitive Dementia Patient Cohort.
J Clin Neurol. 2020 Jul;16(3):433-437. doi: 10.3988/jcn.2020.16.3.433.
2
Emergency Department Use by Community-Dwelling Individuals With Dementia in the United States: An Integrative Review.
J Gerontol Nurs. 2018 Mar 1;44(3):23-30. doi: 10.3928/00989134-20171206-01. Epub 2018 Jan 23.
3
A review of the methods used to estimate the cost of Alzheimer's disease in the United States.
Am J Alzheimers Dis Other Demen. 2011 Jun;26(4):298-309. doi: 10.1177/1533317511407481. Epub 2011 May 11.

本文引用的文献

1
Cost of illness of Alzheimer's disease: how useful are current estimates?
Gerontologist. 2003 Apr;43(2):158-64. doi: 10.1093/geront/43.2.158.
2
Memantine in moderate-to-severe Alzheimer's disease.
N Engl J Med. 2003 Apr 3;348(14):1333-41. doi: 10.1056/NEJMoa013128.
3
Cognitive function and acute care utilization.
J Gerontol B Psychol Sci Soc Sci. 2003 Jan;58(1):S38-49. doi: 10.1093/geronb/58.1.s38.
4
The costs of vascular dementia: a comparison with Alzheimer's disease.
J Neurol Sci. 2002 Nov 15;203-204:35-9. doi: 10.1016/s0022-510x(02)00257-5.
5
Healthcare utilization and costs in managed care patients with Alzheimer's disease during the last few years of life.
J Am Geriatr Soc. 2001 Sep;49(9):1156-60. doi: 10.1046/j.1532-5415.2001.49231.x.
6
The relative effect of Alzheimer's disease and related dementias, disability, and comorbidities on cost of care for elderly persons.
J Gerontol B Psychol Sci Soc Sci. 2001 Sep;56(5):S285-93. doi: 10.1093/geronb/56.5.s285.
7
How much do persons with Alzheimer's disease cost Medicare?
J Am Geriatr Soc. 2000 Jun;48(6):639-46. doi: 10.1111/j.1532-5415.2000.tb04721.x.
9
Assessing the societal impact of acetylcholinesterase inhibitor therapies.
Alzheimer Dis Assoc Disord. 1999 Nov;13 Suppl 2:S9-19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验